Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2009 | 08-2008 | 08-2007 | 08-2006 | 08-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 10 | 140 | 360 | 80 |
| Receivables | 0 | 0 | 0 | 50 | 60 |
| Other current assets | 9 | 80 | 230 | 50 | 30 |
| TOTAL | $10 | $90 | $370 | $460 | $170 |
| Non-Current Assets | |||||
| PPE Net | 3 | 5 | 200 | 110 | 200 |
| Investments And Advances | 3 | 0 | 10 | 10 | 0 |
| Other Non-Current Assets | 4 | 142 | 20 | 80 | 80 |
| TOTAL | $10 | $147 | $230 | $200 | $280 |
| Total Assets | $20 | $240 | $610 | $660 | $450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 260 | 260 | 80 | 280 | 90 |
| Accrued Expenses | 100 | 120 | 130 | 40 | 0 |
| Other current liabilities | 2 | 90 | 0 | 40 | 0 |
| TOTAL | $1,470 | $1,920 | $1,950 | $1,270 | $180 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 360 | 810 | 680 | 0 | 0 |
| TOTAL | $360 | $810 | $680 | $N/A | $10 |
| Total Liabilities | $1,830 | $2,730 | $2,630 | $1,270 | $190 |
| Shareholders' Equity | |||||
| Common Shares | 150 | 110 | 70 | 60 | 40 |
| Retained earnings | -57,070 | -54,490 | -49,900 | -42,260 | -36,170 |
| Other shareholders' equity | 10 | 10 | 10 | 0 | 90 |
| TOTAL | $-1,810 | $-2,490 | $-2,020 | $-600 | $260 |
| Total Liabilities And Equity | $20 | $240 | $610 | $670 | $450 |